Patent · US Active

Diagnosis of cancer by detecting dimeric IL-18

US10288618B2 · kind B2 · utility

1Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 2, 2015
Grant dateMay 14, 2019
Priority date
Expiry dateApr 2, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention describes methods for screening for cancer in a subject, by measuring the level of dimeric IL-18 in a sample obtained from the subject, and comparing that level with the level in a normal control sample.The present invention also describes an assay for screening for cancer in a subject, by measuring the level of dimeric IL-18 in a sample obtained from the subject, whereby an elevated level of dimeric IL-18 is indicative of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.